1. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000. 13:686–707.
Article
2. Lee WG, Park IJ, Jin HY, Park MH. Relapse and reacquisition of rectal colonization by vancomycin-resistant Enterococcus faecium after decolonization. Epidemiol Infect. 2010. 138:1449–1453.
3. Montecalvo MA, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1995. 16:680–685.
4. Gholizadeh Y, Courvalin P. Acquired and intrinsic glycopeptide resistance in enterococci. Int J Antimicrob Agents. 2000. 16:S1. S11–S17.
Article
5. Sherer CR, Sprague BM, Campos JM, Nambiar S, Temple R, Short B, et al. Characterizing vancomycin-resistant enterococci in neonatal intensive care. Emerg Infect Dis. 2005. 11:1470–1472.
Article
6. Singh N, Léger MM, Campbell J, Short B, Campos JM. Control of vancomycin-resistant enterococci in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2005. 26:646–649.
Article
7. Ergaz Z, Arad I, Bar-Oz B, Peleg O, Benenson S, Minster N, et al. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak. J Hosp Infect. 2010. 74:370–376.
Article
8. Yüce A, Karaman M, Gülay Z, Yulug N. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis. 2001. 33:803–805.
9. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995. 33:2233–2239.
Article
10. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995. 33:1434.
Article
11. Woodford N, Adebiyi AM, Palepou MF, Cookson BD. Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother. 1998. 42:502–508.
Article
12. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol. 2002. 40:1963–1971.
13. Freitas AR, Tedim AP, Novais C, Ruiz-Garbajosa P, Werner G, Laverde-Gomez JA, et al. Global spread of the hyl(Efm) colonization-virulence gene in megaplasmids of the Entercoccus faecium CC17 polyclonal subcluster. Antimicrob Agents Chemother. 2010. 54:2660–2665.
14. Galloway-Peña JR, Nallapareddy SR, Arias CA, Elipoulos GM, Murray BE. Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J Infect Dis. 2009. 200:1566–1573.
15. Bonora MG, Olioso D, Lo Cascio G, Fontana R. Phylogenetic analysis of vancomycin-resistant Enterococcus faecium genotypes associated with outbreaks or sporadic infections in Italy. Microb Drug Resist. 2007. 13:171–177.
16. Leavis HL, Bonten MJ, Willems RJ. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol. 2006. 9:454–460.
Article
17. Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, Kettlitz C, et al. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis. 2005. 24:815–825.